Inga Hofmann, MD

• Myelodysplastic Syndromes

Dr. Hofmann is an assistant professor of pediatric hematology, oncology and the Director of Pediatric Stem Cell Transplant program at the UW School of Medicine and Public Health (SMPH). She received her MD degree from Albert Ludwigs University of Freiburg, Germany and completed her pediatric residency at the University of California in San Francisco. Dr. Hofmann also completed her clinical fellowship in pediatric hematology and oncology at the Dana-Farber/Boston Children’s Cancer and Blood Disorder Center at Harvard Medical School, and her post-doctoral fellowship in hematopathology and pediatric hematopathology at the Brigham and Women’s Hospital in Boston and Boston Children’s Hospital. At Boston Children’s Hospital, she discovered her passion for cell therapy. She became devoted to the rare childhood bone marrow failure and myelodysplastic syndromes (MDS). Dr.Hofmann created a national registry of patients and their blood samples in the hopes of completing research to help develop treatments for these often fatal diseases. As the Medical Director, Dr. Hofmann manages the interaction between patients, SMPH, American Family Children’s Hospital clinical trials office and PACT as the program manufactures a variety of cell types to conduct first-in-human clinical trials.